Estimating the cost-effectiveness of daclatasvir plus asunaprevir in difficult to treat Japanese patients chronically infected with hepatitis C genotype 1b
Hepatology research, 2016-04, Vol.46 (5), p.423-433 [Peer Reviewed Journal]2015 The Japan Society of Hepatology ;2015 The Japan Society of Hepatology. ;ISSN: 1386-6346 ;EISSN: 1872-034X ;DOI: 10.1111/hepr.12570 ;PMID: 26440999
Full text available